OUTLOOK THERAPEUTICS Company Leadership

OTLK Stock  USD 0.39  0.04  9.30%   
About 66 percent of all OUTLOOK THERAPEUTICS's insiders are acquiring. The analysis of the overall insider sentiment regarding OUTLOOK THERAPEUTICS INC suggests that many insiders are confidant. OUTLOOK THERAPEUTICS employs about 17 people. The company is managed by 15 executives with a total tenure of roughly 34 years, averaging almost 2.0 years of service per executive, having 1.13 employees per reported executive.
Ralph Thurman  Chairman
Executive Chairman of the Board
Elizabeth Yamashita  President
Vice President - Regulatory Affairs

Insider Sentiment 66

 Mostly Buying

 
Selling
 
Buying

Latest Trades

2024-09-26Lawrence A KenyonAcquired 5000 @ 5.69View
2024-03-28Yezan Munther HaddadinAcquired 1882 @ 11.82View
2023-04-20Terry DagnonDisposed 26000 @ 22.8View
Monitoring OUTLOOK THERAPEUTICS's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

OUTLOOK THERAPEUTICS Management Team Effectiveness

The company has return on total asset (ROA) of (1.7682) % which means that it has lost $1.7682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0365) %, meaning that it created substantial loss on money invested by shareholders. OUTLOOK THERAPEUTICS's management efficiency ratios could be used to measure how well OUTLOOK THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, OUTLOOK THERAPEUTICS's Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 0.000002 this year, although the value of Return On Tangible Assets are projected to rise to (0.000003). At this time, OUTLOOK THERAPEUTICS's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 22.4 T this year, although the value of Non Current Liabilities Other will most likely fall to about 52.5 K.
Common Stock Shares Outstanding is expected to rise to about 30.8 M this year, although the value of Net Loss will most likely fall to (62.4 M). OUTLOOK THERAPEUTICS owns a total of 73.51 Million outstanding shares. OUTLOOK THERAPEUTICS has large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2014-12-31
Previous Quarter
37 M
Current Value
53.9 M
Avarage Shares Outstanding
8.2 M
Quarterly Volatility
11.4 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Dividend Yield is expected to rise to about 73.8 K this year, although the value of Dividends Paid will most likely fall to about 181.5 B. Common Stock Shares Outstanding is expected to rise to about 30.8 M this year, although the value of Net Loss will most likely fall to (62.4 M).

OUTLOOK THERAPEUTICS Workforce Comparison

OUTLOOK THERAPEUTICS INC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 381. OUTLOOK THERAPEUTICS holds roughly 17.0 in number of employees claiming about 4% of equities under Health Care industry.

OUTLOOK THERAPEUTICS Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OUTLOOK THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on OUTLOOK THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, OUTLOOK THERAPEUTICS insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

OUTLOOK THERAPEUTICS Notable Stakeholders

An OUTLOOK THERAPEUTICS stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OUTLOOK THERAPEUTICS often face trade-offs trying to please all of them. OUTLOOK THERAPEUTICS's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OUTLOOK THERAPEUTICS's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bob JahrCEO DirectorProfile
Russell IIICEO PresidentProfile
Robert JahrCEO PresidentProfile
Ralph ThurmanExecutive Chairman of the BoardProfile
Elizabeth YamashitaVice President - Regulatory AffairsProfile
Jennifer KissnerSenior Vice President Clinical DevelopmentProfile
Alicia TozierMarketing PresidentProfile
Lawrence CPACFO, EVPProfile
Terry DagnonChief OfficerProfile
Balu BalasubramanianAdvisorProfile
Jeffrey EvansonChief OfficerProfile
Jedd ComiskeySenior EuropeProfile
Joel PrieveVP OperationsProfile
Rick GregoryDirector CommunicationsProfile
Surendra MDSenior AffairsProfile
String symbol = request.getParameter("s");

About OUTLOOK THERAPEUTICS Management Performance

The success or failure of an entity such as OUTLOOK THERAPEUTICS INC often depends on how effective the management is. OUTLOOK THERAPEUTICS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OUTLOOK management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OUTLOOK management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year

OUTLOOK THERAPEUTICS Workforce Analysis

Traditionally, organizations such as OUTLOOK THERAPEUTICS use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OUTLOOK THERAPEUTICS within its industry.

OUTLOOK THERAPEUTICS Manpower Efficiency

Return on OUTLOOK THERAPEUTICS Manpower

Revenue Per Employee83.1B
Revenue Per Executive94.2B
Net Loss Per Employee3.7T
Net Loss Per Executive4.2T
When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.79)
Revenue Per Share
0.041
Quarterly Revenue Growth
6.583
Return On Assets
(1.77)
Return On Equity
(0.04)
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.